Delivery Order SPE2DB22D1017-SPE2DB24FF3ME
Award Date 2/29/24
Potential Completion Date 3/1/24
Potential Value $1.4K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $1,225.44 firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver a comprehensive range of pharmaceutical products and medical supplies to military treatment...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, with a potential value of $2,042.64 and a completion date of February 7, 2024. This contract is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this award and has also received...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of 4563881637 NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a potential value of $2,067.44 and a completion date of March 7, 2024. This award is not associated with a set-aside program. The contract is part of a larger indefinite delivery contract (IDC) awarded solely to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $1,225.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp to supply a range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML. The contract has a potential value of $1,225.44 and a completion date of February 12, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside designations. Amerisourcebergen Drug Corp also holds an...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The award has a completion date of February 23, 2024 and a potential value of $1,225.44. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The award, valued at $1,225.44, has a completion date of February 7, 2024. This delivery order is likely part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of up to...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, valued at $1,225.44. The contract has a completion date of February 1, 2024. This delivery order is one of many indefinite delivery contracts (IDCs) held by Amerisourcebergen Drug Corp with DLA, which serve as the primary...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a delivery order contract valued at $2,576.12 by the Defense Logistics Agency (DLA) to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product. The contract is a firm fixed price delivery order with a completion date of February 14, 2024. This award is not associated with any set-aside designation. Amerisourcebergen Drug Corp serves as the prime contractor for this order, which supports DLA...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The contract has a potential value of $1,225.44 and a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any set-aside program. In addition to this specific award, Amerisourcebergen...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3MEDelivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order from the Defense Logistics Agency (DLA) Troop Support Medical to provide NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals. The $1,370.47 contract has a completion date of March 1, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a comprehensive range of medications and healthcare materials to military treatment programs and medical facilities worldwide under the Department of Defense.
Generated 5/30/24, 10:08 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 2/29/24 |